I knew that participating in a clinical trial for an Alzheimer’s drug was unlikely to help me. But it gave me hope. So when the news broke this week that the drug company Biogen had canceled its once-promising trial because of “disappointing results,” I felt like I’d been punched in the stomach. The night before Biogen canceled the trial, I realized that I was losing 12 years of memories of my cherished dog Abe, who died from kidney disease last year. My phone began to ring, followed by Facebook messages: “Did you see the news today?”

Source: New York Times March 22, 2019 16:41 UTC